Zobrazeno 1 - 10
of 223 654
pro vyhledávání: '"monoclonal-antibody"'
Autor:
Bryan III, Miles R.1 (AUTHOR), Tian, Xu1 (AUTHOR), Tseng, Jui-Heng1 (AUTHOR), Evangelista, Baggio A.1 (AUTHOR), Ragusa, Joey V.2 (AUTHOR), Bryan, Audra F.1 (AUTHOR), Trotman, Winifred3 (AUTHOR), Irwin, David3 (AUTHOR), Cohen, Todd J.1,2,4 (AUTHOR) toddcohen@neurology.unc.edu
Publikováno v:
Acta Neuropathologica Communications. 10/12/2024, Vol. 12 Issue 1, p1-18. 18p.
Autor:
Lawton, Graham (AUTHOR)
Publikováno v:
New Scientist. 8/31/2024, Vol. 263 Issue 3506, p32-35. 4p. 3 Color Photographs.
Autor:
Tu, S. Sean1, Holman, Christopher M.2
Publikováno v:
Berkeley Technology Law Journal. 2023, Vol. 38 Issue 1, p1-50. 50p.
Autor:
Severin, G. W.1,2,3 (AUTHOR) gwseverin@chemistry.msu.edu, Fonslet, J.1,4 (AUTHOR), Kristensen, L. K.4,5 (AUTHOR), Nielsen, C. H.4,5 (AUTHOR), Jensen, A. I.1 (AUTHOR), Kjær, A.5 (AUTHOR), Mazar, A. P.6 (AUTHOR), Johnston, K.7 (AUTHOR), Köster, U.8 (AUTHOR)
Publikováno v:
Scientific Reports. 3/9/2022, Vol. 12 Issue 1, p1-7. 7p.
Autor:
Lauren Taylor Rosenblum, ReidAnn E. Sever, Ryan Gilbert, David Guerrero, Sarah R. Vincze, Dominic M. Menendez, Peggy A. Birikorang, Mikayla R. Rodgers, Ambika Parmar Jaswal, Alexander C. Vanover, Joseph D. Latoche, Angel G. Cortez, Kathryn E. Day, Lesley M. Foley, Chaim T. Sneiderman, Itay Raphael, T. Kevin Hitchens, Jessie R. Nedrow, Gary Kohanbash, W. Barry Edwards, Marcus M. Malek
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-12 (2024)
Abstract Background Surgical resection is integral for the treatment of neuroblastoma, the most common extracranial solid malignancy in children. Safely locating and resecting primary tumor and remote deposits of disease remains a significant challen
Externí odkaz:
https://doaj.org/article/46a524a2699743eba0f0f099fc8cbf76
Autor:
Yaru Yang, Hongyan Qiu, Yuru Fan, Qin Zhang, Huiling Qin, Juan Wu, Xuan Zhang, Yueyue Liu, Renpeng Zhou, Qian Zhang, Zi Ye, Jingyue Ma, Ye Xu, Sheng Feng, Yue Fei, Na Li, Xiaojing Cui, Fangli Dong, Quanren Wang, Kai Shen, Sepehr Shakib, Jasmine Williams, Wei Hu
Publikováno v:
Alzheimer’s Research & Therapy, Vol 16, Iss 1, Pp 1-11 (2024)
Abstract Background SHR-1707 is a novel humanized anti-Aβ IgG1 monoclonal antibody that binds to Aβ fibrils and monomers to block the formation of Aβ plaques or to promote the microglial phagocytosis of Aβ. Preclinical studies showed that SHR-170
Externí odkaz:
https://doaj.org/article/c235061a1161431ba736e7493e4d3bee
Autor:
Mohammad Arastoo, Lewis K. Penny, Richard Lofthouse, Aya Abdallah, Anna Abrahamsson, Pietro Marini, Valeria Melis, Gernot Riedel, Charles R. Harrington, Claude M. Wischik, Andrew Porter, Soumya Palliyil
Publikováno v:
Alzheimer’s Research & Therapy, Vol 16, Iss 1, Pp 1-20 (2024)
Abstract Background Recent advances in blood-based biomarker discovery are paving the way for simpler, more accessible diagnostic tools that can detect early signs of Alzheimer’s disease (AD). Recent successes in the development of amyloid-targetin
Externí odkaz:
https://doaj.org/article/3efb8c85249a4d3e81c8e65617f504f9
Autor:
Chenfei Zhou, Jinling Jiang, Xiaojun Xiang, Hongli Liu, Guowu Wu, Ruichao Zeng, Tong Lu, Mengqi Zhang, Yuteng Shen, Min Hong, Jun Zhang
Publikováno v:
Experimental Hematology & Oncology, Vol 13, Iss 1, Pp 1-14 (2024)
Abstract Background Blocking cytotoxic T lymphocyte-associated antigen-4 (CTLA-4) shows substantial antitumor efficacy. Here, we report the preclinical data and outcomes of a first-in-human phase 1a trial of JS007, a novel anti-CTLA-4 antibody, in ad
Externí odkaz:
https://doaj.org/article/31cceefc2b274d07b0c1bbd9ea2b4b65
Publikováno v:
International Journal of Nanomedicine, Vol Volume 19, Pp 10045-10064 (2024)
Kai-Wen Ho,1,2 Yen-Ling Liu,2,3 Tzu-Yi Liao,2,3 En-Shuo Liu,2,3 Tian-Lu Cheng1– 3 1Department of Biomedical Science and Environmental Biology, Kaohsiung Medical University, Kaohsiung, Taiwan; 2Drug Development and Value Creation Research Center, Ka
Externí odkaz:
https://doaj.org/article/0eb622f7f2f347a0851ad70a691f38c9
Publikováno v:
The Journal of Headache and Pain, Vol 25, Iss 1, Pp 1-10 (2024)
Abstract Background Efficacy and safety of human monoclonal antibody erenumab used for migraine prophylaxis have been shown in clinical studies. APOLLON is an open-label, multi-center, single arm study, which permits dose adjustments of erenumab and
Externí odkaz:
https://doaj.org/article/e6ecff1ce47745e68f685768d79638bf